| 2024/05/10 22:26:35 | |
|---|---|
| Price | |
| 4.665 EUR | |
| Difference | -3.03% (-0.15) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 666 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | 4.618 EUR (649) |
| Ask (Ask size) | 4.711 EUR (636) |
| Open | 4.696 EUR |
| High | 4.706 EUR |
| Low | 4.696 EUR |
| Close (prev. day) | 4.811 EUR |
| VWAP | 4.70448 EUR |
| Volume (pcs) | 460 |
| Trading volume | 2,164.06 |
| Number of trades | 2 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/10 22:26:35 | |
|---|---|
| Price | |
| 4.665 EUR | |
| Difference | -3.03% (-0.15) |
General attributes
| ISIN | CA05156V1022 |
| Symbol | AUPH |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 666 EUR |
| Benchmark | S&P/TSX 60 INDEX |
Market data
| Bid (Bid size) | 4.618 EUR (649) |
| Ask (Ask size) | 4.711 EUR (636) |
| Open | 4.696 EUR |
| High | 4.706 EUR |
| Low | 4.696 EUR |
| Close (prev. day) | 4.811 EUR |
| VWAP | 4.70448 EUR |
| Volume (pcs) | 460 |
| Trading volume | 2,164.06 |
| Number of trades | 2 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -35.00% | -54.04% | -42.85% |
| Perf (abs.) | -2.53 | -5.53 | -3.53 |
| Beta | 1.08 | 1.22 | 1.65 |
| Volatility | 59.06 | 55.17 | 80.75 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 4.772 EUR (92) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 4.701 EUR (458) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 6.025 EUR (1,145) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 7.498 EUR (1,285) |
| YTD High | date | 8.530 EUR (2024/01/09) |
| YTD Low | date | 4.434 EUR (2024/04/18) |
| 52 Weeks High | date | 11.660 EUR (2023/07/31) |
| 52 Weeks Low | date | 4.434 EUR (2024/04/18) |
All listings for AURINIA PHARMACEUTICALS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/10 | 22:26 | 4.665 EUR | 0.00 | 2 |
| Stuttgart | 2024/05/10 | 08:02 | 4.768 EUR | 0.00 | 3 |
| Nasdaq | 2024/05/10 | 22:00 | 5.02 USD | 6.02 | 7,925 |
| Munich | 2024/05/10 | 08:03 | 4.791 EUR | 0.00 | 1 |
| London Stock Exchange | 2021/02/05 | 16:52 | 19.6090 CAD | 0.00 | 1 |
| Frankfurt | 2024/05/10 | 21:41 | 4.579 EUR | 0.00 | 3 |
| Duesseldorf | 2024/05/10 | 19:32 | 4.644 EUR | 0.00 | 5 |
| Berlin | 2024/05/10 | 08:13 | 4.768 EUR | 0.00 | 2 |
Company Profile
| - |
Board of directors
| Daniel Billen | Chairman of Supervisory Board |
| Brinda Balakrishnan | Member of Supervisory Board |
| David Jaynee | Member of Supervisory Board |
| Karen Smith | Member of Supervisory Board |
| Robert Foster | Member of Supervisory Board |
| Jeffrey Bailey | Member of Supervisory Board |
| Jill Leversage | Member of Supervisory Board |
| R. MacKay-Dunn | Member of Supervisory Board |